Barclays PLC Acquires New Holdings in Electromed, Inc. (NYSE:ELMD)

Barclays PLC acquired a new stake in shares of Electromed, Inc. (NYSE:ELMD) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,022 shares of the company’s stock, valued at approximately $215,000.

Several other institutional investors also recently bought and sold shares of ELMD. Marshall Wace LLP purchased a new position in Electromed during the second quarter valued at approximately $256,000. Walleye Capital LLC purchased a new position in Electromed during the third quarter valued at approximately $274,000. Navellier & Associates Inc. purchased a new position in Electromed during the third quarter valued at approximately $368,000. State Street Corp increased its holdings in Electromed by 14.5% during the third quarter. State Street Corp now owns 22,066 shares of the company’s stock valued at $474,000 after buying an additional 2,800 shares during the period. Finally, Pekin Hardy Strauss Inc. purchased a new position in Electromed during the second quarter valued at approximately $522,000. 40.82% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Andrew Summers sold 12,731 shares of Electromed stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $29.98, for a total transaction of $381,675.38. Following the completion of the sale, the director now directly owns 165,755 shares in the company, valued at approximately $4,969,334.90. The trade was a 7.13 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 14.00% of the company’s stock.

Electromed Trading Up 1.8 %

NYSE ELMD opened at $31.23 on Tuesday. The firm’s fifty day simple moving average is $28.08 and its two-hundred day simple moving average is $21.23. Electromed, Inc. has a 12-month low of $9.81 and a 12-month high of $31.88. The firm has a market capitalization of $264.14 million, a P/E ratio of 43.38 and a beta of 0.31.

Electromed (NYSE:ELMD) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.13. Electromed had a net margin of 11.34% and a return on equity of 15.32%. The business had revenue of $14.67 million for the quarter.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.